AMVUTTRA Trademark

Trademark Overview


On Sunday, October 3, 2021, a trademark application was filed for AMVUTTRA with the United States Patent and Trademark Office. The USPTO has given the AMVUTTRA trademark a serial number of 97057473. The federal status of this trademark filing is REGISTERED as of Tuesday, November 8, 2022. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The AMVUTTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of amyloidosis
amvuttra

General Information


Serial Number97057473
Word MarkAMVUTTRA
Filing DateSunday, October 3, 2021
Status700 - REGISTERED
Status DateTuesday, November 8, 2022
Registration Number6897159
Registration DateTuesday, November 8, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements


Description of MarkThe mark consists of the word AMVUTTRA and the design of a stylized double helix.
Goods and ServicesPharmaceutical preparations for the treatment of amyloidosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code005
First Use Anywhere DateFriday, July 1, 2022
First Use In Commerce DateTuesday, July 5, 2022

Trademark Owner History


Party NameAlnylam Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Wednesday, October 6, 2021NEW APPLICATION ENTERED
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 29, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, December 18, 2021ASSIGNED TO EXAMINER
Saturday, December 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 15, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 15, 2022USE AMENDMENT FILED
Friday, July 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 1, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, September 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 1, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED